Aiolos Bio | Investor profile | Foundersuite

Investor info

Type

Fund of Funds

Stage focus

Early stage VC

Industry focus

Description

Aiolos Bio is a clinical-stage biotechnology company focused on developing novel therapies for immune-mediated diseases and cancers by targeting tissue-resident memory T cells. Their innovative approach aims to provide safer and more effective treatments for patients with autoimmune and inflammatory disorders.

Previous investments

Company
Amount
Round

Example example company Inc
1000000
Investor meetings
Company & Company
11000000
Series C funding
Example
524000
Seed round A

Connected people

Email visible after logging in

Example Exampleexample[email protected]
Example Exampleexample
Notexample Examplenotexample example[email protected]
Example Examplenotexampleexample example[email protected]
Example Exampleexample[email protected]
Example Exampleexample[email protected]

See other investors focused on

Biotechnology

Other investors you may be interested in